Moderna is already riding high on the strength of its mRNA-based COVID-19 vaccine, but the broader potential of its technology has been shown in a new AstraZeneca-partnered candidate for he
After being hailed as a triumph of public-private drug development, Moderna's partnership with the US government on its COVID-19 vaccine looks like it may descend into acrimony.
Germany's vaccination advisory committee has recommended that people aged under 30 should only be offered Pfizer/BioNTech's COVID-19 vaccine Comirnaty, saying it seems less likely to cause
The FDA has said it needs more time to review Moderna's application for emergency use of its COVID-19 vaccine mRNA-1273 in children aged 12 to 17, as it looks at data on heart inflammation
The US looks set to see a big expansion of the country's COVID-19 vaccination drive, with shots looking likely for children aged five to 11 as well as a fourth dose for adults who are immun
FDA advisors will meet later today discuss the possibility of authorising Pfizer and BioNTech's COVID-19 vaccine Comirnaty in children as young as five years old.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.